Company	Drug	Indication

Emergent BioSolutions Inc.	BioThrax	Anthrax
Protalix BioTherapeutics Inc.	Etelyso	Type I Gaucher disease

Today's news in brief

BioWorld

BioWorld briefs for April 18, 2024.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for April 18, 2024.

AACR 24: Freezing, of all things, is one way to heat cold tumors

BioWorld

“Hot and cold tumors may need different types of immunotherapy,” Jay Berzofsky told the audience as the American Association for Cancer Research’s (AACR) 2024...

AACR 2024: Getting older younger may be driving rise in early-onset cancers

BioWorld

As with most common diseases of the developed world, aging is the major risk factor for developing cancer. Most of the half-dozen hallmarks of precancer that were...

More biosimilars from China, US encroach on Amgen’s denosumab

BioWorld

Biosimilar competition to Amgen Inc.’s denosumab (Prolia/Xgeva) is rising globally, with Mabwell (Shanghai) Bioscience Co. Ltd. gaining the latest China NMPA...

Upgrade your daily dose of biopharma and medtech news

FDA Approvals In May